Terminology Service for NFDI4Health
Letrozole/Leuprolide/Palbociclib Regimen
Go to external page
http://purl.obolibrary.org/obo/NCIT_C160550
A chemotherapy regimen consisting of letrozole, leuprolide and palbociclib that can be used in the treatment of estrogen receptor (ER)-positive and HER-2/neu-negative metastatic or advanced breast cancer. [ ]
Term info
Label
Letrozole/Leuprolide/Palbociclib Regimen
Synonyms
- Femara/Lupron/Ibrance
- Letrozole-Leuprolide-Palbociclib
- Letrozole/Leuprolide/Palbociclib
- Letrozole/Leuprolide/Palbociclib Regimen
Subsets
NCIT_C160952, NCIT_C160950
Preferred Name
Letrozole/Leuprolide/Palbociclib Regimen
Semantic Type
Therapeutic or Preventive Procedure
code
C160550